Publications of Udo Reichl
All genres
Journal Article (267)
1.
Journal Article
12 (7), 755 (2024)
Parallel Multifactorial Process Optimization and Intensification for High-Yield Production of Live YF17D-Vectored Zika Vaccine. Vaccines 2.
Journal Article
108 (1), 240 (2024)
Production of recombinant vesicular stomatitis virus-based vectors by tangential flow depth filtration. Applied Microbiology and Biotechnology 3.
Journal Article
15, 1434301 (2024)
Detection, isolation and characterization of phage-host complexes using BONCAT and click chemistry. Frontiers in Microbiology 4.
Journal Article
4 (1), ycae153 (2024)
Tracing active members in microbial communities by BONCAT and click chemistry-based enrichment of newly synthesized proteins. ISME Communications 5.
Journal Article
250, 121020 (2024)
Breakdown of hardly degradable carbohydrates (lignocellulose) in a two-stage anaerobic digestion plant is favored in the main fermenter. Water Research 6.
Journal Article
81, pp. 10 - 25 (2024)
Model-based optimization of cell-free enzyme cascades exemplified for the production of GDP-fucose. Metabolic Engineering 7.
Journal Article
20 (5), e1012190 (2024)
Macrophage- and CD4+ T cell-derived SIV differ in glycosylation, infectivity and neutralization sensitivity. PLOS Pathogens 8.
Journal Article
17, 66 (2024)
Improved biological methanation using tubular foam-bed reactor. Biotechnology for Biofuels and Bioproducts 9.
Journal Article
108, 97 (2024)
Production of antiviral “OP7 chimera” defective interfering particles free of infectious virus. Applied Microbiology and Biotechnology 10.
Journal Article
27 (4), 109421 (2024)
Mathematical model calibrated to in vitro data predicts mechanisms of antiviral action of the influenza defective interfering particle “OP7”. iScience 11.
Journal Article
24 (4), 2300245 (2024)
From single‐cell cloning to high‐yield influenza virus production – implementing advanced technologies in vaccine process development. Engineering in Life Sciences 12.
Journal Article
20 (1), 2373521 (2024)
Innovations in cell culture-based influenza vaccine manufacturing – from static cultures to high cell density cultivations. Human Vaccines & Immunotherapeutics 13.
Journal Article
24 (21), e202300463 (2023)
A Cell‐Free Multi‐enzyme Cascade Reaction for the Synthesis of CDP‐Glycerol. ChemBioChem: A European Journal of Chemical Biology 14.
Journal Article
28 (4), 1843 (2023)
Reliable N-Glycan Analysis–Removal of Frequently Occurring Oligosaccharide Impurities by Enzymatic Degradation. Molecules 15.
Journal Article
26, pp. 132 - 150 (2023)
Removable Dyes—The Missing Link for In-Depth N-glycan Analysis via Multi-Method Approaches. Engineering 16.
Journal Article
13, 20936 (2023)
Generation of “OP7 chimera” defective interfering influenza A particle preparations free of infectious virus that show antiviral efficacy in mice. Scientific Reports 17.
Journal Article
120 (9), pp. 2639 - 2657 (2023)
Process intensification strategies toward cell culture‐based high‐yield production of a fusogenic oncolytic virus. Biotechnology and Bioengineering 18.
Journal Article
120, pp. 3335 - 3346 (2023)
Characterization of a quail suspension cell line for production of a fusogenic oncolytic virus. Biotechnology and Bioengineering 19.
Journal Article
107, pp. 5947 - 5961 (2023)
Production of retroviral vectors in continuous high cell density culture. Applied Microbiology and Biotechnology 20.
Journal Article
9 (1), 67 (2023)
Degradation Kinetics of Lignocellulolytic Enzymes in a Biogas Reactor Using Quantitative Mass Spectrometry. Fermentation